Cited by 181Neurogenesis and neuroplasticity mechanismsMesenchymal stem cell researchPluripotent Stem Cells Research

The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.

Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection

De Feo, Donatella, Merlini, Arianna, Laterza, Cecilia, Martino, Gianvito·2012·Current Opinion in Neurology

Abstract

PURPOSE OF REVIEW: Transplantation of neural stem/precursor cells (NPCs) has been proposed as a promising therapeutic strategy in almost all neurological disorders characterized by the failure of central nervous system (CNS) endogenous repair mechanisms in restoring the tissue damage and rescuing the lost function. Nevertheless, recent evidence consistently challenges the limited view that transplantation of these cells is solely aimed at protecting the CNS from inflammatory and neurodegenerative damage through cell replacement. RECENT FINDINGS: Recent preclinical data confirmed that transplanted NPCs may also exert a 'bystander' neuroprotective effect and identified a series of molecules - for example, immunomodulatory substances, neurotrophic growth factors, stem cell regulators as well as guidance molecules - whose in-situ secretion by NPCs is temporally and spatially orchestrated by environmental needs. A better understanding of the molecular and cellular mechanisms sustaining this 'therapeutic plasticity' is of pivotal importance for defining crucial aspects of the bench-to-beside translation of neural stem cell therapy, that is route and timing of administration as well as the best cellular source. Further insight into those latter issues is eagerly expected from the ongoing phase I/II clinical trials, while, on the other hand, new cellular sources are being developed, mainly by exploiting the new possibilities offered by cellular reprogramming. SUMMARY: Nowadays, the research on NPC transplantation in neurological disorders is advancing on two different fronts: on one hand, recent preclinical data are uncovering the molecular basis of NPC therapeutic plasticity, offering a more solid rational framework for the design of clinical studies. On the other hand, pilot trials are highlighting the safety and feasibility issues of neural stem cell transplantation that need to be addressed before efficacy could be properly evaluated.

Overview

Integrity signals

Registry

Crossref · 10.1097/wco.0b013e328352ec45

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 4

  1. Korbling, 2003, Adult stem cells for tissue repair - a new therapeutic concept N Engl J M, ed, 349, 570
  2. Atkins, 2012, Autologous hematopoietic stem cell transplantation for autoimmune disease - is it now ready for prime time Biol Blood Marrow T, ransplant, 18, S177
  3. Uccelli, 2011, Mesenchymal stem cells for multiple sclerosis: does neural differentiation really matter Curr Stem Cell Res T, her, 6, 69
  4. Ingber, 2007, What lies at the interface of regenerative medicine and developmental biology D, evelopment, 134, 2541

Cited by

Sorted by citations

See all 181

Metadata

Authors
De Feo, D., Merlini, A., Laterza, C., & Martino, G.
Affiliations
Vita-Salute San Raffaele University (IT)
Corresponding author
Martino, Gianvito
Venue
Current Opinion in Neurology
Published
2012-06
Volume
25
Issue
3
Pages
322-333
ISSN
1350-7540 (ISSN-L)
OpenAlex
W2056328978
Cited by
181
References
102
Citations by year
2026: 1 · 2025: 8 · 2024: 5 · 2023: 6 · 2022: 11 · 2021: 14 · 2020: 12 · 2019: 16 · 2018: 10 · 2017: 11 · 2016: 20 · 2015: 23 · 2014: 13 · 2013: 25 · 2012: 5
FWCI
2.73
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (publishedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Keywords
neural stem cell transplantation, neural progenitor cells, central nervous system disorders, immunomodulation, neurotrophic factors, guidance molecules, cellular reprogramming, clinical translation, feasibility and safety, neurodegeneration, inflammation
MeSH terms
Central Nervous System Diseases, Humans, Neuroprotective Agents, Stem Cell Transplantation, Neural Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review